ALPN logo

Alpine Immune Sciences (ALPN) Working Capital

ALPN Annual Working Capital

$288.05 M
+$105.06 M+57.41%

31 December 2023

ALPN Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ALPN Quarterly Working Capital

$276.01 M
-$12.04 M-4.18%

01 March 2024

ALPN Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ALPN Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+57.4%+89.6%
3 y3 years+336.9%+89.6%
5 y5 years+534.2%+89.6%

ALPN Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall timeat high-4.2%

Alpine Immune Sciences Working Capital History

DateAnnualQuarterly
Mar 2024
-
$276.01 M(-4.2%)
Dec 2023
$288.05 M(+57.4%)
$288.05 M(+97.8%)
Sept 2023
-
$145.60 M(-5.4%)
June 2023
-
$153.91 M(+8.6%)
Mar 2023
-
$141.69 M(-22.6%)
Dec 2022
$183.00 M(+49.7%)
$183.00 M(-1.0%)
Sept 2022
-
$184.78 M(+68.5%)
June 2022
-
$109.67 M(+1.6%)
Mar 2022
-
$107.93 M(-11.7%)
Dec 2021
$122.23 M(+85.4%)
$122.23 M(+2.0%)
Sept 2021
-
$119.82 M(+50.7%)
June 2021
-
$79.49 M(+39.2%)
Mar 2021
-
$57.12 M(-13.4%)
Dec 2020
$65.93 M(+96.1%)
$65.93 M(-38.2%)
Sept 2020
-
$106.70 M(+69.2%)
June 2020
-
$63.06 M(+91.2%)
Mar 2020
-
$32.98 M(-1.9%)
Dec 2019
$33.62 M
$33.62 M(-13.3%)
Sept 2019
-
$38.78 M(-13.2%)
DateAnnualQuarterly
June 2019
-
$44.67 M(-20.3%)
Mar 2019
-
$56.05 M(+23.4%)
Dec 2018
$45.42 M(-43.7%)
$45.42 M(-19.2%)
Sept 2018
-
$56.21 M(-17.8%)
June 2018
-
$68.37 M(-8.9%)
Mar 2018
-
$75.06 M(-6.9%)
Dec 2017
$80.65 M(+46.2%)
$80.65 M(-5.5%)
Sept 2017
-
$85.36 M(+85.4%)
June 2017
-
$46.05 M(-6.3%)
Mar 2017
-
$49.15 M(-10.9%)
Dec 2016
$55.16 M(-33.8%)
$55.16 M(-10.7%)
Sept 2016
-
$61.79 M(-9.6%)
June 2016
-
$68.34 M(-10.2%)
Mar 2016
-
$76.14 M(-8.6%)
Dec 2015
$83.27 M(+219.9%)
$83.27 M(-6.6%)
Sept 2015
-
$89.18 M(-6.1%)
June 2015
-
$94.97 M(+335.1%)
Mar 2015
-
$21.83 M(-16.1%)
Dec 2014
$26.03 M(-1278.3%)
$26.03 M
Dec 2013
-$2.21 M
-

FAQ

  • What is Alpine Immune Sciences annual working capital?
  • What is the all time high annual working capital for Alpine Immune Sciences?
  • What is Alpine Immune Sciences annual working capital year-on-year change?
  • What is Alpine Immune Sciences quarterly working capital?
  • What is the all time high quarterly working capital for Alpine Immune Sciences?
  • What is Alpine Immune Sciences quarterly working capital year-on-year change?

What is Alpine Immune Sciences annual working capital?

The current annual working capital of ALPN is $288.05 M

What is the all time high annual working capital for Alpine Immune Sciences?

Alpine Immune Sciences all-time high annual working capital is $288.05 M

What is Alpine Immune Sciences annual working capital year-on-year change?

Over the past year, ALPN annual working capital has changed by +$105.06 M (+57.41%)

What is Alpine Immune Sciences quarterly working capital?

The current quarterly working capital of ALPN is $276.01 M

What is the all time high quarterly working capital for Alpine Immune Sciences?

Alpine Immune Sciences all-time high quarterly working capital is $288.05 M

What is Alpine Immune Sciences quarterly working capital year-on-year change?

Over the past year, ALPN quarterly working capital has changed by +$130.42 M (+89.57%)